loadpatents
name:-0.02173113822937
name:-0.011803865432739
name:-0.017905950546265
Beeharry; Neil Patent Filings

Beeharry; Neil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beeharry; Neil.The latest application filed is for "pikfyve inhibitors for cancer therapy".

Company Profile
17.11.21
  • Beeharry; Neil - Guilford CT
  • Beeharry; Neil - Philadelphia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Apilimod compositions and methods for using same
Grant 11,266,654 - Lichenstein , et al. March 8, 2
2022-03-08
Apilimod compositions and methods for using same in the treatment of renal cancer
Grant 11,166,944 - Beeharry , et al. November 9, 2
2021-11-09
Pikfyve Inhibitors For Cancer Therapy
App 20210077500 - Landrette; Sean ;   et al.
2021-03-18
Method For Treating Cancer Using Hsp90 Inhibitors
App 20210030759 - Beeharry; Neil ;   et al.
2021-02-04
Anti-viral Compositions Containing Pikfyve Inhibitors And Use Thereof
App 20200360397 - Lichenstein; Henri ;   et al.
2020-11-19
Methods for treating cancer using HSP90 inhibitors
Grant 10,799,508 - Beeharry , et al. October 13, 2
2020-10-13
Apilimod Compositions And Methods For Using Same In The Treatment Of Renal Cancer
App 20200297706 - Beeharry; Neil ;   et al.
2020-09-24
Apilimod for use in the treatment of melanoma
Grant 10,765,682 - Beeharry , et al. Sep
2020-09-08
Apilimod Compositions And Methods For Using Same
App 20200268764 - Lichenstein; Henri ;   et al.
2020-08-27
Therapeutic Methods Relating To Hsp90 Inhibitors
App 20200253979 - Kind Code
2020-08-13
Anti-viral compositions containing PIKfyve inhibitors and use thereof
Grant 10,729,694 - Lichenstein , et al.
2020-08-04
Methods for treating cancer using apilimod
Grant 10,350,213 - Lichenstein , et al. July 16, 2
2019-07-16
Apilimod For Use In The Treatment Of Colorectal Cancer
App 20190209576 - BEEHARRY; Neil ;   et al.
2019-07-11
Apilimod For Use In The Treatment Of Renal Cancer
App 20190201385 - Beeharry; Neil ;   et al.
2019-07-04
Apilimod Compositions and Methods for Using Same
App 20190183902 - Lichenstein; Henri ;   et al.
2019-06-20
Therapeutic Methods Relating To Hsp90 Inhibitors
App 20190091229 - Lichenstein; Henri ;   et al.
2019-03-28
Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
Grant 10,220,051 - Bellacosa , et al.
2019-03-05
Apilimod for use in the treatment of renal cancer
Grant 10,206,910 - Beeharry , et al. Feb
2019-02-19
Biomarkers for Treating Cancer with Apilimod
App 20190015421 - Gayle; Sophia ;   et al.
2019-01-17
Apilimod compositions and methods for using same
Grant 10,179,135 - Lichenstein , et al. Ja
2019-01-15
Methods for treating cancer using HSP90 inhibitors
App 20180221376 - Beeharry; Neil ;   et al.
2018-08-09
Active Metabolites Of Apilimod And Uses Thereof
App 20180078561 - Beckett; Paul ;   et al.
2018-03-22
Anti-viral Compositions Containing Pikfyve Inhibitors And Use Thereof
App 20180028540 - LICHENSTEIN; Henri ;   et al.
2018-02-01
Apilimod For Use In The Treatment Of Renal Cancer
App 20170333408 - BEEHARRY; Neil ;   et al.
2017-11-23
Apilimod For Use In The Treatment Of Melanoma
App 20170333439 - BEEHARRY; Neil ;   et al.
2017-11-23
Methods for Treating Cancer Using Apilimod
App 20170020884 - Lichenstein; Henri ;   et al.
2017-01-26
Apilimod Compositions and Methods for Using Same
App 20170007613 - Lichenstein; Henri ;   et al.
2017-01-12
Sensitization of cancer cells to DNA damage by inhibiting kinases essential for DNA damage checkpoint control
Grant 9,421,203 - Yen , et al. August 23, 2
2016-08-23
Combination Of Dna Repair Inhibition With Bendamustine Or Gemcitabine In The Treatment Of Cancer
App 20150164934 - BELLACOSA; ALFONSO ;   et al.
2015-06-18
Sensitization Of Cancer Cells To Dna Damage By Inhibiting Kinases Essential For Dna Damage Checkpoint Control
App 20150133466 - Yen; Timothy ;   et al.
2015-05-14
Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
Grant 8,927,516 - Bellacosa , et al. January 6, 2
2015-01-06
Combination Of Dna Repair Inhibition With Bendamustine Or Gemcitabine In The Treatment Of Cancer
App 20130303588 - Bellacosa; Alfonso ;   et al.
2013-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed